产热
脂肪细胞
内科学
内分泌学
白色脂肪组织
胰岛素抵抗
过氧化物酶体增殖物激活受体
产热素
吡格列酮
脂肪组织
生物
化学
胰岛素
受体
医学
2型糖尿病
糖尿病
作者
Carolline Santos Miranda,Flávia Maria Silva-Veiga,Daiana Araujo Santana-Oliveira,Isabela Macedo Lopes Vasques-Monteiro,Julio Beltrame Daleprane,Vanessa Souza‐Mello
出处
期刊:Nutrition
[Elsevier]
日期:2023-10-07
卷期号:117: 112253-112253
被引量:3
标识
DOI:10.1016/j.nut.2023.112253
摘要
The aim of this study was to investigate the role of peroxisome proliferator-activated receptor (PPAR) activation (single PPARα or PPARγ, and dual PPARα/γ) on UCP1-dependent and -independent thermogenic pathways and mitochondrial metabolism in the subcutaneous white adipose tissue of mice fed a high-fat diet. Male C57BL/6 mice received either a control diet (10% lipids) or a high-fat diet (HF; 50% lipids) for 12 wk. The HF group was divided to receive the treatments for 4 wk: HFγ (pioglitazone, 10 mg/kg), HFα (WY-14643, 3.5 mg/kg), and HFα/γ (tesaglitazar, 4 mg/kg). The HF group was overweight, insulin resistant, and had subcutaneous white adipocyte dysfunction. Treatment with PPARα and PPARα/γ reduced body mass, mitigated insulin resistance, and induced browning with increased UCP1-dependent and -independent thermogenesis activation and improved mitochondrial metabolism to support the beige adipocyte phenotype. PPARα and dual PPARα/γ activation recruited UCP1+ beige adipocytes and favored UCP1-independent thermogenesis, yielding body mass and insulin sensitivity normalization. Preserved mitochondrial metabolism emerges as a potential target for obesity treatment using PPAR agonists, with possible clinical applications.
科研通智能强力驱动
Strongly Powered by AbleSci AI